Business of Personalized Medicine Summit
Just as with patient treatments, one size does not fit all when it comes to companies involved in personalized medicine. Each is unique in its mission, culture, and capabilities, and so it should come as no surprise that each demands a distinct business strategy that can evolve alongside the industry. The 2015 BPM Summit is centered around helping attendees build just that — a successful, sustainable business model that allows them to realize the promise of personalized medicine.
Co-hosted by Foley & Lardner LLP, the Personalized Medicine Coalition, AmerisourceBergen, and the California Life Sciences Association, this one-day, one-of-a-kind thought leadership and networking forum features an agenda focused on the critical business questions, issues, and opportunities related to funding, research and development, public policy and regulation, technology, and more. Through fresh discussions with key opinion leaders and each other, attendees will collect insights and arrive at solutions that will drive their individual growth and performance as well as impact the overall future of health care.
- Financing & Venture Capital
- Big Pharma
- Intellectual Property
- Big Data
- Disruptive Innovation
- Clinical Adoption
Featured AmerisourceBergen Speakers
- Perry Dimas, SVP and General Manager, Premier Source
Payment Panel: Strategies for identifying your target market, collecting evidence, and getting paid
- Vicki Albrecht, PhD, Vice President, Strategy, Provider Solutions, AmerisourceBergen
Clinical Adoption Breakout Session
- Trent McLaughlin, BSc(Pharm), PhD, Vice President, Scientific Client Strategies, Xcenda
Big Data Breakout Session